OptiNose, Inc. (OPTN)
9.60
-0.11 (-1.13%)
Inactive · Last trade price on May 20, 2025
OptiNose Revenue
OptiNose had revenue of $18.51M in the quarter ending March 31, 2025, with 24.40% growth. This brings the company's revenue in the last twelve months to $81.86M, up 10.58% year-over-year. In the year 2024, OptiNose had annual revenue of $78.23M with 10.20% growth.
Revenue (ttm)
$81.86M
Revenue Growth
+10.58%
P/S Ratio
1.31
Revenue / Employee
$639,500
Employees
128
Market Cap
97.22M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 78.23M | 7.24M | 10.20% |
Dec 31, 2023 | 70.99M | -5.29M | -6.93% |
Dec 31, 2022 | 76.28M | 1.62M | 2.18% |
Dec 31, 2021 | 74.65M | 25.54M | 51.99% |
Dec 31, 2020 | 49.12M | 14.49M | 41.83% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionOPTN News
- 5 months ago - OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc. - OPTN - Business Wire
- 7 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BECN and OPTN on Behalf of Shareholders - GlobeNewsWire
- 7 months ago - Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call - GlobeNewsWire
- 7 months ago - Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS) - GlobeNewsWire
- 9 months ago - Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million - GlobeNewsWire
- 10 months ago - Optinose Announces 1-for-15 Reverse Stock Split - GlobeNewsWire
- 11 months ago - Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 11 months ago - OptiNose, Inc. (OPTN) Q3 2024 Earnings Call Transcript - Seeking Alpha